Novartis Pharma B.V.
Location
Noord-Holland
Founded
1948-02-10
Website
Risk Signals
21161 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Novartis Pharma B.V.
Live alerts from global media, monitored by Business Radar
2024-11-22 (kffhealthnews.org)
FDA Lifts 3-Year Block On Study Of Marijuana Benefits For PTSD In Vets
Meanwhile, cannabis progress could stop under the Trump administration; a labeling issue prompts a recall of the popular drug Clonazepam; Novartis acquires Kate Therapeutics; and more.
Read more
2024-11-22 (kffhealthnews.org)
FDA Lifts 3-Year Block On Study Of Marijuana Benefits For PTSD In Vets
Meanwhile, cannabis progress could stop under the Trump administration; a labeling issue prompts a recall of the popular drug Clonazepam; Novartis acquires Kate Therapeutics; and more.
Read more
2024-10-09 (jiho.jp)
Novartis Launches Another Recall of Comtan over Nitrosamine Impurities
Novartis Pharma on October 8 initiated a voluntary recall of certain batches of its peripheral catec…
Read more
2024-10-09 (jiho.jp)
Novartis Launches Another Recall of Comtan over Nitrosamine Impurities
Novartis Pharma on October 8 initiated a voluntary recall of certain batches of its peripheral catec…
Read more
2024-05-07 (packagingdigest.com)
Closure failure behind Novartis OTC recall
Novartis Consumer Health has announced that it is voluntarily recalling certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactu
Read more
2024-05-07 (packagingdigest.com)
Closure failure behind Novartis OTC recall
Novartis Consumer Health has announced that it is voluntarily recalling certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactu
Read more
2024-02-21 (thepharmaletter.com)
Novartis recalls Adakveo in the UK
Novartis recalls Adakveo in the UK
Read more
2024-02-21 (thepharmaletter.com)
Novartis recalls Adakveo in the UK
Novartis recalls Adakveo in the UK
Read more
2024-01-27 (dokuzeylul.com)
Novartis denied the allegations: We did not withdraw from Turkey
Novartis emphasized that they are working to prevent patients and their relatives from suffering, and stated that they will continue their activities in the country and contribute to healthcare services. Novartis' statement stated that the company did not withdraw from Turkey and continued its activities in the country.
Read more
2024-01-26 (ekonomist.com.tr)
The famous pharmaceutical company denied the claim that it would withdraw from Turkey
Novartis stated that all information and comments regarding their withdrawal from Turkey are unfounded.
Read more
2024-01-26 (gazeteduvar.com.tr)
Novartis: We did not withdraw from Turkey
Novartis made a statement regarding the allegations that they withdrew from Turkey: "We would like to inform the public that we will continue to contribute to the growth and development of our country."
Read more
2024-01-22 (rtn.ch)
Sandoz strengthens in the United States with the purchase of a biosimilar
The pharmaceutical group Sandoz has announced the purchase of the drug Cimerli, a biosimilar of the product Lucentis, from the company Coherus, to strengthen its position in the ophthalmology sector in the United States.
Read more